Glassman Wealth Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-130	Closed	-$114K	–	1445
2023 Q4	$114K	Buy	130 +3	+2%	+$2.47K	0.02%	273
2023 Q3	$105K	Sell	127 -1	-0.8%	-$786	0.02%	268
2023 Q2	$92K	Buy	128 +4	+3%	+$3.08K	0.01%	277
2023 Q1	$102K	Buy	124 +7	+6%	+$5.28K	0.02%	264
2022 Q4	$84.4K	Buy	117 +8	+7%	+$5.9K	0.02%	298
2022 Q3	$75K	Buy	109 +9	+9%	+$5.67K	0.02%	300
2022 Q2	$59K	Sell	100 -2	-2%	-$1.3K	0.01%	354
2022 Q1	$71K	Buy	102 +25	+32%	+$15.8K	0.01%	325
2021 Q4	$49K	Buy	77 +33	+75%	+$20.3K	0.01%	378
2021 Q3	$27K	Buy	44 +8	+22%	+$4.97K	0.01%	506
2021 Q2	$20K	Buy	36 +9	+33%	+$4.56K	﹤0.01%	574
2021 Q1	$13K	Hold	27	–	–	﹤0.01%	652
2020 Q4	$13K	Hold	27	–	–	﹤0.01%	652
2020 Q3	$15K	Buy	27 +3	+13%	+$1.82K	﹤0.01%	517
2020 Q2	$15K	Sell	24 -2	-8%	-$1.14K	﹤0.01%	427
2020 Q1	$13K	Buy	26 +16	+160%	+$6.6K	0.01%	401
2019 Q4	$4K	Sell	10 -8	-44%	-$2.69K	﹤0.01%	631
2019 Q3	$5K	Buy	18 +6	+50%	+$1.77K	﹤0.01%	540
2019 Q2	$4K	Sell	12 -15	-56%	-$4.99K	﹤0.01%	600
2019 Q1	$11K	Buy	27 +20	+286%	+$8.24K	﹤0.01%	440
2018 Q4	$3K	Hold	7	–	–	﹤0.01%	504
2018 Q3	$3K	Hold	7	–	–	﹤0.01%	552
2018 Q2	$2K	Buy	7 +1	+17%	+$313	﹤0.01%	580
2018 Q1	$2K	Buy	6 +1	+20%	+$348	﹤0.01%	552
2017 Q4	$2K	Sell	5 -3	-38%	-$1.22K	﹤0.01%	509
2017 Q3	$4K	Buy	8 +3	+60%	+$1.43K	﹤0.01%	374
2017 Q2	$2K	Hold	5	–	–	﹤0.01%	423
2017 Q1	$2K	Sell	5 -1	-17%	-$371	﹤0.01%	455
2016 Q4	$2K	Buy	+6	New	+$2.28K	﹤0.01%	516